Las Vegas, NV -- (SBWIRE) -- 01/14/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Organovo Holdings Inc (NYSEMKT:ONVO), CEL-SCI Corporation (NYSEMKT:CVM), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Cell Therapeutics Inc (NASDAQ:CTIC).
Organovo Holdings Inc (NYSEMKT:ONVO) ended its recent business day with the tumbled of -2.13% and closed at the price of $11.05 after opening at $11.21. The stock traded during its last trading session with the total volume of 10.29 million shares, as compared to its average volume of 3.84 million shares. Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications.
Has ONVO Found The Bottom And Ready To Gain Momentum? Find Out Here
CEL-SCI Corporation (NYSEMKT:CVM) remained among the day bullish 14.51% and traded with volume of 5.26 million shares in the last session, as compared to average volume of 820,720.00 shares. In comparison with 52 week range of $0.53 - $3.09, it faced lowest price of $0.69 during the last trading session whereas its day highest price was $0.83. The company’s total market capitalization is $38.60 Million, along with 48.85 million shares outstanding. CEL-SCI Corporation is engaged in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer.
Will CVM Continue To Move Higher? Find out via this report
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) showed 10.05 million shares in volume during the last trading session, while the average trading volume remained 8.96 million shares. The stock kicked off its trading session at $13.80 and closed at $12.87 after dropped -6.20%. Himax Technologies, Inc. designs, develops, and markets semiconductors for flat panel displays.
Will HIMX Get Buyers Even After The Recent Rally? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) stock traded during its last trading session with the total traded volume of 10.27 million shares versus its average volume of 3.29 million shares. The company opened its trade at the price of $3.00 and its closing price was $2.92 after gained 9.77% for the day. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
For How Long CTIC will Fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)